TOP - Daily

Challenges prevail in the US population when it comes to transforming behaviors and risk factors related to cancer death.

New retrospective study results show that amiodarone, a widely used arrhythmia medication, may increase the risk of developing cancer.

Patients receiving chemotherapy often experience chemotherapy-induced peripheral neuropathy that for up to 40% of patients may persist for months or years following chemotherapy treatments.

Many women whose breast cancer expresses the hormones estrogen or progesterone are recommended a daily intake of tamoxifen or aromatase inhibitors for 5 years.

A recently published study shows that when treating prostate cancer, intermittent androgen deprivation therapy is not as beneficial as continuous androgen deprivation.

According to recent study results, women aged 75 years and older were at an increased risk for breast cancer mortality when an extended period of time existed between their last mammogram and a breast cancer diagnosis.

On average, African American men experience a longer wait time between prostate cancer diagnosis and treatment than do Caucasian men.

The increased cancer survival population will offer distinctive healthcare challenges in the future.

Breast cancer mortality may also be greater for those patients taking combined hormone therapy.

New guidelines related to the care of multiple myeloma patients not participating in clinical trials were recently published.